Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$32.0M
101M shares
52-week range
$0.16 – $1.32
15% from low
Sector
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Exchange
NASDAQ
CS
P/S (TTM)
0.3
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
www.cosmoshealthinc.comNo one on the platform currently holds COSM.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 390,500 | $123.9K |
| Execution date | Ratio |
|---|---|
| 2022-12-16 | 1-for-25reverse |
| 2017-11-21 | 1-for-10reverse |
No one on the platform has traded COSM yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | 19.9% | 3.3% | ||||
| Profit Margin % | -29.3% | -27.1% | -19.6% | |||
| Free Cash Flow Margin % | -13.0% | -23.8% | -22.0% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $81M | +25.5% | $-0.21 | $-0.21–$-0.21 | — | 1 |
| 2027 | $111M | +37.1% | $0.07 | $0.07–$0.07 | 4.9× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-19 | $-0.10 | $-0.10 | +0.0% |
| 2026-05-20 | $-0.01 | $-0.02 | -100.0% |
| 2026-04-15 | $-0.04 | $-0.14 | -250.0% |
| 2025-11-14 | $-0.01 | $-0.17 | -1600.0% |
| 2025-08-15 | $0.01 | $-0.10 | -1084.0% |
| 2025-05-15 | $-0.03 | $-0.03 | -4.7% |
| 2025-04-15 | $-0.09 | $-0.50 | -455.6% |
| 2024-11-14 | $-0.11 | $-0.45 | -309.1% |
| $25M |
| — |
| LSTALisata Therapeutics, Inc. | $1.70 | -2.30% | $15M | — |
| MTVAMetaVia Inc. | $1.73 | +8.81% | $4M | — |
Source: Financial Modeling Prep · peers by sector/industry
$COSM https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cosmos-health-adds-5.2-million-units-in-new-five-year-agreements-with-1221094
View on StockTwits ↗
$COSM If this doesn't drop below $0.24... I'm in for an epic run.
View on StockTwits ↗
$COSM .33 when this has to start reaching $1 (200%) by mid Nov or face a Reverse Split or delisting ... and this looks good to some?
View on StockTwits ↗
$COSM BAD NEWS FOLKS! My sources are telling me this is down bigly overseas. Imagine the poor suckers who bought this Friday at .34 during the pump ... ouch! Monday is already a done deal !!
View on StockTwits ↗
$COSM Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June
View on StockTwits ↗$COSM https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cosmos-health-adds-5.2-million-units-in-new-five-year-agreements-with-1221094
View on StockTwits ↗
$COSM Positive momentum keeps the setup interesting!
View on StockTwits ↗
$COSM Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June
View on StockTwits ↗$COSM https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cosmos-health-adds-5.2-million-units-in-new-five-year-agreements-with-1221094
View on StockTwits ↗
$COSM I’m so anxiously excited to see what awaits for us this week!
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.